SecBot SecBot
PRESS-RELEASE ·Filed Mar 6, 2026

VTAK

Catheter Precision, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Monitor for follow-up announcements on hospital evaluations or purchase orders; this visibility event may lead to incremental adoption but lacks immediate financial catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VTAK ▼ -34.75% at T+60d
NEUTRAL call -34.75% · α vs SPY -47.53% · entry $1.41 → $0.9200
Entry = T+0 close
Mar 6, 2026
via day close
T+1d
-2.84%
call -2.84% · α -3.68%
$1.37
settled 8mo ago
T+5d
-3.55%
call -3.55% · α -2.02%
$1.36
settled 8mo ago
T+20d
-32.62%
call -32.62% · α -30.58%
$0.9500
settled 7mo ago
T+60d
-34.75%
call -34.75% · α -47.53%
$0.9200
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Catheter Precision, Inc. (VTAK) announced that its LockeT suture retention device will be featured in live procedural cases at the International Symposium of Left Atrial Appendage 2026, a key cardiovascular conference. The company aims to increase physician adoption through hands-on demonstrations with electrophysiology fellows, highlighting potential cost savings and same-day discharge benefits.

Key Facts

  • LockeT device to be showcased in live cases at ISLAA 2026 conference in Los Angeles.
  • Event attended by leading physicians from institutions including Mayo Clinic, Mt. Sinai, and Texas Cardiac Arrhythmia Institute.
  • Catheter Precision providing hands-on training for electrophysiology fellows.
  • LockeT is FDA-registered Class 1 device with CE Mark approval.
  • No financial figures, revenue impact, or commercial agreements disclosed.

Financial Impact

No quantifiable financial impact disclosed

Risk Factors

  • Forward-looking statements about adoption and value may not materialize.
  • No guarantee that conference exposure will translate into sales or market share gains.
  • Company has low market cap ($2M), indicating high risk and limited liquidity.

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3250987
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 8h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 6, 2026